Perkins Adelene Q 4
4 · BRUKER CORP · Filed Feb 18, 2026
Research Summary
AI-generated summary of this filing
Bruker Director Adelene Q. Perkins Receives 4,520 RSU Award
What Happened Adelene Q. Perkins, a director of Bruker Corporation (BRKR), received a grant of 4,520 restricted stock units (RSUs) on February 15, 2026. The reported acquisition price is $0.00 (typical for compensation awards). According to the filing, the RSUs will vest in one installment on February 15, 2027, and each RSU will automatically convert into one share of common stock on the vesting date.
Key Details
- Transaction date and type: 2026-02-15 — Award/Grant of RSUs (code A)
- Shares granted: 4,520 RSUs; acquisition price: $0.00
- Vesting: One installment on 2027-02-15; RSUs convert to common shares at vesting (see footnote)
- Shares owned after transaction: Not specified in the excerpt of the filing
- Filing date: Form 4 filed 2026-02-18 (report covers 2026-02-15) — no late-filing flag noted in this summary
Context This is a compensation award (RSUs), not an open-market purchase or sale. RSU grants are a routine form of executive/director compensation and only become actual shares if/when they vest; they do not necessarily indicate immediate buying or selling activity. The footnote clarifies conversion to shares on the single vesting date one year from grant.
Insider Transaction Report
- Award
Common Stock
[F1]2026-02-15+4,520→ 29,144 total
Footnotes (1)
- [F1]This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock.